Form 4 for TECH Bio-Techne
Accepted 2026-04-16 16:19:36 ET · period of report 2026-04-14 · accession 0000914190-26-000070 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-16 16:19 | 2026-04-14 | TECH | Kelderman Kim | CEO, Dir | M - OptEx | $0.00 | +36.5K | 85.2K | +75% | $0 |
| D | 2026-04-16 16:19 | 2026-04-14 | TECH | Kelderman Kim | CEO, Dir | F - Tax | $58.66 | -32.1K | 53.1K | -38% | -$1.88M |
| D | 2026-04-16 16:19 | 2026-04-14 | TECH | Kelderman Kim | CEO, Dir | M - OptEx | $0.00 | -36.5K | 73.0K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-14 | M | A | 36,500 | $0.00 | 85,165 | D | — | — | |
| 2 | Common | Common Stock | 2026-04-14 | F | D | 32,088 | $58.66 | 53,077 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-04-14 | M | D | 36,500 | $0.00 | 73,036 | D | $47.60 · — to 2026-08-07 | 36,500 Common Stock | (F1) Fully exercisable. |